On 28 January 2026, PW Medtech Group Limited (01358) released a Next Day Disclosure Return indicating its total number of issued shares remains at 1,473,589,098. The announcement shows that from 23 September 2025 to 28 January 2026, the company executed multiple share repurchases at prices ranging from HKD 1.28 to HKD 1.555, including the final repurchase of 255,000 shares on 28 January 2026 at HKD 1.28.

According to the disclosure, 15,573,000 shares have been repurchased from the date of the 10 June 2025 mandate through 28 January 2026, representing approximately 1.0475% of the issued shares at the time the mandate was granted. The company confirms all procedures complied with relevant listing requirements, and a moratorium on new share issuances or treasury share sales extends until 27 February 2026.